Summer Sale

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Get 30% Off

Up to 30% off — ends 7 Aug

ONLY00h00m00s

JIN SEOK KIM

Associate Professor

Severance Hospital

South Korea

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Internal Medicine

70%

Pharmacotherapy

70%

Hematology

60%

Lymphoma

40%

Graft-versus-host Disease

40%

Targeted Therapy

40%

Antibody Therapy

40%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles22

Real-World Use of carfilzomib-lenalidomide-dexamethasone (KRd) and carfilzomib-dexamethasone (Kd) in Relapsed/Refractory Multiple Myeloma in the Asia Pacific Region: A Prospective Multicenter Observational Study

Article Link

Year:

2025

NKG2D-mediated cytotoxicity of CD4 cytotoxic T cells in multiple myeloma

Article Link

Year:

2025

Imaging in plasma cell disorders—consensus recommendations of the Asian myeloma network bone imaging workgroup

Article Link

Year:

2025

Prevention and Management of Thromboembolism in Patients with Paroxysmal Nocturnal Hemoglobinuria in Asia: A Narrative Review

Article Link

Year:

2025

Long-Term Outcomes of COVID-19 and Risk Factors for Prolonged or Persistent COVID-19 in Lymphoma Patients: A Multicenter, Retrospective Cohort Study

Article Link

Year:

2024

Clinical outcomes of etoposide and cytarabine as consolidation in elderly patients with primary CNS lymphoma

Article Link

Year:

2024

Phase 3 randomized COMMODORE 1 trial: Crovalimab versus eculizumab in complement inhibitor‐experienced patients with paroxysmal nocturnal hemoglobinuria

Article Link

Year:

2024

Poor Mobilization-Associated Factors in Autologous Hematopoietic Stem Cell Harvest

Article Link

Year:

2024

A Multicenter Analysis of Clinical Features and Long-Term Outcomes of POEMS Syndrome in Korea

Article Link

Year:

2024

Impact of Lactate Dehydrogenase and Hemoglobin Levels on Clinical Outcomes in Patients With Paroxysmal Nocturnal Hemoglobinuria: Results From the National Korean PNH Registry

Article Link

Year:

2024

Monitoring and Treatment of Paroxysmal Nocturnal Hemoglobinuria in Patients with Aplastic Anemia in Asia: An Expert Consensus

Article Link

Year:

2024

Real‐world data for the use of emicizumab in haemophilia A patients with inhibitors – First nationwide report from Korea

Article Link

Year:

2023

The first successful eculizumab rescue therapy of a kidney transplant recipient with atypical hemolytic uremic syndrome in South Korea: a case report

Article Link

Year:

2023

DRP1 Inhibition Enhances Venetoclax-Induced Mitochondrial Apoptosis in TP53-Mutated Acute Myeloid Leukemia Cells through BAX/BAK Activation

Article Link

Year:

2023

Long-Term Efficacy and Safety of Eculizumab in Patients With Paroxysmal Nocturnal Hemoglobinuria and High Disease Burden: Real-World Data From Korea

Article Link

Year:

2023

Real‐world data on prognostic value of measurable residual disease assessment by fragment analysis or next‐generation sequencing in multiple myeloma

Article Link

Year:

2022

Limited benefits of thalidomide and dexamethasone maintenance after autologous stem cell transplantation in newly diagnosed multiple myeloma patients: a prospective phase II multi-center study in Korea

Article Link

Year:

2022

Subgroup analysis based on cytogenetic risk in patients with relapsed or refractory multiple myeloma in the CANDOR study

Article Link

Year:

2022

Long-term efficacy and safety of CT-P10 or rituximab in untreated advanced follicular lymphoma: a randomized phase 3 study

Article Link

Year:

2021

Risk factors for neutropenic fever in non-Hodgkin’s lymphoma patients with primary granulocyte colony-stimulating factor prophylaxis

Article Link

Year:

2021

Open-label, single arm, multicenter phase II study of VIDL induction chemotherapy followed by upfront autologous stem cell transplantation in patients with advanced stage extranodal NK/T-cell lymphoma

Article Link

Year:

2021

Safety, pharmacokinetics, and pharmacodynamics of a next‐generation subcutaneously administered coagulation factor IX variant, dalcinonacog alfa, in previously treated hemophilia B patients

Article Link

Year:

2021

Collaborators22

Seung Min Hahn

Yonsei University College of Medicine

SOUTH KOREA

Soo Mee Bang

Seoul National University Hospital

SOUTH KOREA

Je-Hwan Lee

Professor

Asan Medical Center, University of Ulsan College of Medicine

SOUTH KOREA

Ola Landgren

Professor of Medicine

Sylvester Comprehensive Cancer Center, University of Miami

UNITED STATES

Kihyun Kim

professor

Sungkyunkwan University School of Medicine

SOUTH KOREA

Doh Yu Hwang

Associate professor

Yonsei University College of Medicine

SOUTH KOREA

Do Young Kim

Pusan National University Yangsan Hospital

SOUTH KOREA

Sangmin Ahn

Yonsei University College of Medicine

SOUTH KOREA

Kyu Ha Huh

Professor

Severance Hospital

SOUTH KOREA

Yong Kyun Won

Assistant professor

Soonchunhyang University College of Medicine

SOUTH KOREA

Ja Min Byun

Clinical Assistant Professor

Seoul National University Hospital

SOUTH KOREA

Joon Sup Yeom

Professor

Yonsei University College of Medicine

SOUTH KOREA

Yong Park

Seoul National University Hospital

SOUTH KOREA

Hyunsoo Cho

Assistant Professor

Yonsei University College of Medicine

SOUTH KOREA

Young Shil Park

SOUTH KOREA

Jong Wook Lee

SOUTH KOREA

yu ri kim

Yonsei University Health System

SOUTH KOREA

Soo-Jeong Kim

Yonsei University Health System

SOUTH KOREA

Deog-Yeon Jo

Chungnam National University School of Medicine

SOUTH KOREA

Sung‐Soo Yoon

SOUTH KOREA

Minsun Jung

Yonsei University College of Medicine

SOUTH KOREA

Seung Hyeok Han

Professor

SOUTH KOREA

How do I reach out?

Meet Kite AI